Testing effectiveness (Phase 2)Study completedNCT03126019What this trial is testingINCB050465 in Relapsed or Refractory Follicular LymphomaWho this might be right forLymphoma Incyte Corporation 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT04533581What this trial is testingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Who this might be right forIndolent B-cell Non-Hodgkin's Lymphoma Kyowa Kirin Co., Ltd. 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT04842877What this trial is testingStudy of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell LymphomaWho this might be right forLymphoma, B-Cell The Lymphoma Academic Research Organisation 141
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Early research (Phase 1)Looking for participantsNCT06547528What this trial is testingA Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLLWho this might be right forRelapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Ono Pharmaceutical Co., Ltd. 108
Testing effectiveness (Phase 2)Study completedNCT02433795What this trial is testingBendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)Who this might be right forMarginal Zone B-cell Lymphoma Seoul National University Hospital 27
Early research (Phase 1)Study completedNCT03498430What this trial is testingCopanlisib Chinese PK StudyWho this might be right forLymphoma, Non-Hodgkin Bayer 13
Large-scale testing (Phase 3)Study completedNCT00329030What this trial is testingRituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)Who this might be right forLymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin National Heart, Lung, and Blood Institute (NHLBI) 224
Testing effectiveness (Phase 2)UnknownNCT04850664What this trial is testingComputerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use DisorderWho this might be right forOpioid Use Disorder, ModerateOpioid Use Disorder, SevereWithdrawal Symptoms+2 more Evon Medics LLC 190
Testing effectiveness (Phase 2)Study completedNCT03145064What this trial is testingStudy of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma BeiGene 41
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Not Yet RecruitingNCT07254793What this trial is testingProphylactic and Therapeutic DLI-X for Leukemia Relapse After HCTWho this might be right forAcute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more University of Arizona 94
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Ended earlyNCT00093704What this trial is testingBortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive LymphomaWho this might be right forLymphomaLymphoproliferative Disorder Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)Active Not RecruitingNCT04447716What this trial is testingAn Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to TreatmentWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more Thomas Jefferson University 4
Early research (Phase 1)Ended earlyNCT04045028What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma Genentech, Inc. 41
Testing effectiveness (Phase 2)UnknownNCT05875428What this trial is testingMitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-Cell Lymphoma CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 104
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Early research (Phase 1)Not Yet RecruitingNCT07335328What this trial is testingFully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell MalignanciesWho this might be right forB-cell Non Hodgkin Lymphoma Medical College of Wisconsin 24
Testing effectiveness (Phase 2)WithdrawnNCT00881387What this trial is testingRituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to TreatmentWho this might be right forLymphoma University of Miami